{"entity":{"type":"insider","cik":"0001272748","url":"/insider/0001272748","json_url":"/insider/0001272748.json","name":"ANDERSON ROBERT EDWARD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":3,"first":"2004-01-22","last":"2004-02-25","span_basis":"filed_date"},"name_variants":[{"name":"ANDERSON ROBERT EDWARD","source":"filing","n_filings":3,"first_seen":"2004-01-22","last_seen":"2004-02-25"}],"transactions":[{"id":9221683,"accession":"0001104659-04-005722","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-04-005722","line_url":"/filing/0001104659-04-005722#line-3","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":26280.0,"total_display":"26,280.00","total_whole":"26,280","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-24","filed_date":"2004-02-25","scope":"insider"},{"id":564796,"accession":"0001104659-04-005644","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-04-005644","line_url":"/filing/0001104659-04-005644#line-3","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":26280.0,"total_display":"26,280.00","total_whole":"26,280","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-24","filed_date":"2004-02-24","scope":"insider"},{"id":9221685,"accession":"0001104659-04-005722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-04-005722","line_url":"/filing/0001104659-04-005722","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":28540.0,"total_display":"28,540.00","total_whole":"28,540","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-23","filed_date":"2004-02-25","scope":"insider","n_lines":2},{"id":564795,"accession":"0001104659-04-005644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-04-005644","line_url":"/filing/0001104659-04-005644","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":28540.0,"total_display":"28,540.00","total_whole":"28,540","shares_owned_after":32400.0,"shares_owned_after_display":"32,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-23","filed_date":"2004-02-24","scope":"insider","n_lines":2},{"id":646948,"accession":"0001104659-04-001460","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-04-001460","line_url":"/filing/0001104659-04-001460","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":7.158,"price_display":"7.16","price_state":"stated","total_value":57264.0,"total_display":"57,264.00","total_whole":"57,264","shares_owned_after":9800.0,"shares_owned_after_display":"9,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-21","filed_date":"2004-01-22","scope":"insider","n_lines":5},{"id":646943,"accession":"0001104659-04-001460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-04-001460","line_url":"/filing/0001104659-04-001460#line-1","is_derivative":false,"issuer_cik":"0001232400","issuer_name":"VASO ACTIVE PHARMACEUTICALS INC","issuer_ticker":"VAPH","issuer_name_source":null,"issuer_url":"/issuer/0001232400","owner_cik":"0001272748","owner_name":"ANDERSON ROBERT EDWARD","owner_display_name":"ANDERSON ROBERT EDWARD","owner_url":"/insider/0001272748","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.6,"price_display":"6.60","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","total_whole":"13,200","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-20","filed_date":"2004-01-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232400","name":"VASO ACTIVE PHARMACEUTICALS INC","url":"/issuer/0001232400","role":"Director","n_filings":3,"first_seen":"2004-01-22","last_seen":"2004-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001272748","retrieved_at":"2026-08-25T20:07:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}